Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population

Ítems similars

• Progression-Free Survival as a Predictor of Overall Survival in Metastatic Renal Cell Carcinoma Treated With Contemporary Targeted Therapy
  per: Heng, Daniel Y. C., et al.
  Publicat: (2010)
• Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
  per: Harshman, Lauren C, et al.
  Publicat: (2012)
• The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients
  per: Al-Marrawi, Mhd Y., et al.
  Publicat: (2013)
• Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy
  per: Heng, D. Y., et al.
  Publicat: (2012)
• First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium
  per: Harshman, Lauren C., et al.
  Publicat: (2014)